April 17, 2026

Claritev Corporation (CTEV) Stock Analysis: Exploring a Potential 117% Upside in Healthcare Tech

Claritev Corporation (NASDAQ: CTEV) presents an intriguing opportunity for investors looking to capitalize on the healthcare technology sector. With a market capitalization of $333.4 million, this..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 438.79% Potential Upside in Biotech

For investors keen on exploring opportunities within the biotechnology sector, Cel-Sci Corporation (CVM) presents a fascinating case. Headquartered in Vienna, Virginia, and trading on the American..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Biotech with 162% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is making waves in the biotechnology sector with a robust focus on developing therapeutic proteins and antibodies aimed at modulating G..

SI-BONE, Inc. (SIBN) Stock Analysis: Potential 90% Upside in the Medical Device Sector

SI-BONE, Inc. (NASDAQ: SIBN), a pivotal player in the medical device industry, has garnered attention for its innovative biomechanical solutions aimed at addressing compromised bone conditions...

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 105% Upside Potential Amid Biotech Innovations

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands at the forefront of the biotechnology sector, boasting an impressive market capitalization of $1.15 billion. Specializing in the development of..

Inventiva S.A. (IVA): Analyst Ratings Reveal 168% Upside Potential in Biotech Sector

Investors keeping an eye on the biotech sector may want to consider Inventiva S.A. (IVA), a France-based clinical-stage biopharmaceutical company that is currently making waves with..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Analyzing the 112.72% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector with its promising pipeline of therapies targeting autoimmune diseases and cancer. The clinical-stage biopharmaceutical..

Butterfly Network, Inc. (BFLY) Stock Analysis: Riding the Wave of 41% Revenue Growth in the Medical Devices Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a promising player in the medical devices industry, is generating significant interest among investors, particularly due to its outstanding 41% revenue..

EyePoint, Inc. (EYPT) Stock Analysis: Unpacking a 150% Potential Upside in the Booming Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is capturing investor attention with a remarkable potential upside of 150.96%, according to current analyst ratings. As a key player in the..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech with 104% Potential Upside

For investors eyeing the healthcare sector, particularly within biotechnology, CorMedix Inc. (NASDAQ: CRMD) presents an intriguing opportunity. This Parsippany, New Jersey-based biopharmaceutical company is in the..

Organogenesis Holdings Inc. (ORGO): Investor Outlook with a 213% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, has captured investor attention with its robust revenue growth and significant potential upside...

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 17.96% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a key player in the healthcare staffing industry, offers a range of talent management services across the United States. With..

AnaptysBio, Inc. (ANAB) Investor Outlook: Unveiling a 19.45% Potential Upside in the Biotech Arena

AnaptysBio, Inc. (NASDAQ: ANAB), a prominent player in the biotechnology sector, is making waves with its promising pipeline of immunology therapeutics. With a market capitalization of..

Avanos Medical, Inc. (AVNS) Stock Analysis: Riding the Wave with a 52-Week High and Strategic Growth in Medical Devices

Avanos Medical, Inc. (NYSE: AVNS) is making waves in the healthcare sector with its robust presence in the medical devices industry. With a market capitalization of..

Verastem, Inc. (VSTM) Stock Analysis: 158% Potential Upside Sparks Investor Interest

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company specializing in cancer treatment, is attracting attention from investors due to its significant upside potential. With a market capitalization..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 62.93% Upside Potential in the Biotech Sector

Pharvaris N.V. (NASDAQ: PHVS) stands out in the healthcare sector as a biotechnology firm focused on addressing rare diseases with a significant unmet need. With a..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the competitive biotechnology sector with its focus on developing and commercializing innovative medicines in the United States. With..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 147% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering player in the biotech industry, is capturing investor attention with its robust potential upside of 147.02%. Specializing in cutting-edge..

Tilray Brands, Inc. (TLRY) Investor Outlook: Potential Upside of Nearly 48% Amid Diverse Product Portfolio

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the healthcare sector and a leader in the drug manufacturing industry, is a focal point for investors..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 128% Potential Upside in Biotech Innovation

For investors with a keen interest in the biotechnology sector, Xencor, Inc. (NASDAQ: XNCR) presents a compelling opportunity, offering an impressive 128.25% potential upside according to..

Search

Funds

April 17, 2026

Search

Funds

April 17, 2026

FTSE 100

Funds